You watched
Catalog
Client
Currency:
+380 66 708 47 52
Our location:
Ternopil city
Phones:
E-mail
We are on social networks
Go to contacts
0 0
Catalog
Main page
Viewed
20
Wishlist
0
Compare
0
Contacts

Marcaine solution for injection 5 mg/ml bottle 20 ml No. 5

SKU: an-7727
0
All about product
Description
Specification
Reviews 0
Questions0
new
Marcaine solution for injection 5 mg/ml bottle 20 ml No. 5
In Stock
625.00 грн.
Buy this product in 1 click:
Active ingredient:Bupivacaine hydrochloride
Adults:Can
ATC code:N NERVOUS SYSTEM AGENTS; N01 ANESTHETICS; N01B LOCAL ANESTHETICS; N01B B Amides; N01B B01 Bupivacaine
Country of manufacture:France
Diabetics:With caution
Delivery
USPS across the USA USPS across the USA
Canada Post across Canada Canada Post across Canada
Payment
Marcaine solution for injection 5 mg/ml bottle 20 ml No. 5
625.00 грн.
Description

Marcaine, 0.5% solution, is used for local anesthesia by percutaneous infiltration, peripheral nerve block(s) and central nerve block (caudal or epidural), i.e., by a specialist in situations where prolonged anesthesia is required. Since sensory nerve block is more pronounced than motor block, Marcaine is particularly effective in relieving pain, for example, during childbirth.

Composition

Active ingredient: bupivacaine;

1 ml of bupivacaine hydrochloride monohydrate equivalent to 5 mg of bupivacaine hydrochloride;

Excipients: sodium chloride, sodium hydroxide and/or hydrochloric acid, water for injections.

Contraindication

Hypersensitivity to amide-type local anesthetics or to any of the other ingredients of the drug. Bupivacaine should not be used for intravenous regional anesthesia (Bieri block). Bupivacaine should not be used for epidural anesthesia in patients with severe hypotension, for example, in the case of cardiogenic or hypovolemic shock. Epidural anesthesia, regardless of the local anesthetic used, has its own contraindications, which include: diseases of the nervous system in the active stage, such as meningitis, poliomyelitis, intracranial hemorrhage, subacute combined degeneration of the spinal cord due to pernicious anemia and tumors of the brain and spinal cord; tuberculosis of the spine; purulent skin infection at or near the site of the lumbar puncture; blood clotting disorders or current treatment with anticoagulants.

Method of application

Marcaine should only be administered by or under the supervision of physicians experienced in regional anesthesia. Small doses should be used to achieve adequate anesthesia.

It is important to take special care to prevent accidental intravascular injection. It is recommended to perform an aspiration test before and during the administration of the total dose. The total dose should be administered slowly, at a rate of 25-50 mg/min or in divided doses, maintaining constant verbal contact with the patient and monitoring the heart rate.

Application features

Pregnant women

Should not be used in early pregnancy unless the benefits are considered to outweigh the risks.

Children

Use for anesthesia in children aged 1 year and older as directed.

Drivers

With caution.

Overdose

Accidental intravascular injections of local anesthetics can cause immediate (seconds to minutes) systemic toxic reactions. In case of overdose, systemic toxicity occurs later (15-60 minutes after injection) due to the slower increase in blood concentrations of the local anesthetic.

Side effects

Adverse reactions caused by the drug itself are difficult to distinguish from the physiological effects of nerve fiber blockade (e.g., decreased blood pressure, bradycardia), as well as phenomena caused directly (e.g., nerve injury) or indirectly (e.g., epidural abscess) by needle puncture.

Interaction

Caution should be exercised when using bupivacaine with drugs structurally similar to local anesthetics, such as class IC antiarrhythmics, as their toxic effects are additive.

Specific interaction studies between local anesthetics and class III antiarrhythmics (e.g. amiodarone) have not been performed, but caution is advised in this case.

Storage conditions

Store at a temperature not exceeding 25 °C.

Do not freeze. Keep out of reach of children.

Shelf life - 3 years.

Specifications
Characteristics
Active ingredient
Bupivacaine hydrochloride
Adults
Can
ATC code
N NERVOUS SYSTEM AGENTS; N01 ANESTHETICS; N01B LOCAL ANESTHETICS; N01B B Amides; N01B B01 Bupivacaine
Country of manufacture
France
Diabetics
With caution
Dosage
5 mg/ml
For allergies
With caution
For children
It is impossible.
Form
Vials
Method of application
Injections
Nursing
With caution as prescribed by a doctor
Pregnant
With caution
Primary packaging
bottle
Producer
AstraZeneca
Quantity per package
5 bottles
Trade name
Marcaine
Vacation conditions
By prescription
Reviews

There are no reviews for this product.

There are no reviews for this product, be the first to leave your review.

Answers & questions
Add your question and we will answer as soon as possible.

No questions about this product, be the first and ask your question.

You are watched
new
Medrolgin solution for injection 30 mg/ml ampoule 1 ml No. 5
In stock
0
385.14 грн.
new
Decasan solution 0.2 mg/ml container 1000 ml
In stock
0
817.76 грн.
new
new
new
new
Sold out
Aclasta solution for infusion 5 mg/100 ml bottle 100 ml No. 1
Распродано
0
12 423.40 грн.
new
Rapten 75 solution for injection ampoule 3 ml No. 5
In stock
0
260.78 грн.
new
Neurodar solution for injection 500 mg/4 ml ampoule No. 5
In stock
0
909.50 грн.
new
Sold out
new
Sold out
Silicone pacifier Avent scf042/27 super soft slow flow No. 2
Распродано
0
446.10 грн.
625.00 грн.